Table 2 Pooled OR and 95% CI of genotype analysis.
From: Association between two CHRNA3 variants and susceptibility of lung cancer: a meta-analysis
SNP | Genotype | Studies | OR(95% CI) | Z | p value | I2(%) |
|---|---|---|---|---|---|---|
rs578776 | TT + CTvsCC | 3 | 0.839(0.718–0.981) | 2.20 | 0.028 | 0.0 |
CC + CTvsTT | 3 | 1.190(0.918–1.542) | 1.31 | 0.189 | 0.0 | |
TTvsCC | 3 | 0.768(0.557–1.061) | 1.60 | 0.109 | 0.0 | |
CTvsCC | 3 | 0.858(0.729–1.010) | 1.84 | 0.066 | 0.0 | |
rs938682 | CC + CTvsTT | 3* | 0.778(0.663–0.912) | 3.10 | 0.002 | 0.0 |
TT + CTvsCC | 3* | 0.989(0.756–1.296) | 0.08 | 0.938 | 0.0 | |
CCvsTT | 4 | 0.724(0.520–1.007) | 1.92 | 0.055 | 60.80 | |
CTvsTT | 4 | 0.767(0.708–0.831) | 6.54 | <0.001 | 0.0 |